Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan B. Rome currently holds 1,258,000 shares of Boston Therapeutics, Inc. (BTHE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan B. Rome has been a net buyer of BTHE stock. They have purchased $625.0K and sold $0 worth of shares.
Jonathan B. Rome's most recent insider trade was on Nov 13, 2012, when they purchased 1,250,000 shares at $0.50 per share.
Jonathan B. Rome serves as Executive at Boston Therapeutics, Inc. (BTHE). They have executed 1 insider transactions totaling $625.0K over their tenure at the company.
Jonathan B. Rome holds the position of Executive at Boston Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Jonathan B. Rome has shown a buying trading pattern, with $625.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jonathan B. Rome was on Nov 13, 2012, when they purchased $625.0K worth of BTHE shares. This transaction involved 1,250,000 shares at $0.50 per share.
Jonathan B. Rome currently owns 1,258,000 shares of Boston Therapeutics, Inc. (BTHE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan B. Rome's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan B. Rome has 1 Form 4 filings on record as an insider at Boston Therapeutics, Inc..
Set alerts for Jonathan B. Rome and 40,000+ other insiders.